Recombinant Neisseria meningitides β1,3-N-acetylhexaminyltransferase (LgtA), E. coli

Cat. No.: XET008Q

Recombinant Neisseria meningitides β1,3-N-acetylhexaminyltransferase (LgtA), E. coli

Synonym: LgtA; Beta1,3-N-Acetyl-hexaminyl-transferase; UDP-N-Acetylglucosamine-lipopolysaccharide N-acetylglucosaminyltransferase

  • Enzyme Commission Number: 2.4.1.56
Product Size
1 unit; 5 units; 10 units
Price
Datasheet
MSDS
Properties
Description
It is an recombinant Neisseria meningitides β1,3-N-acetylhexaminyltransferase (LgtA) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Unit Definition
One unit will catalyze the formation of 1 μmol GlcNAcβ(1-3)Lac from UDP-GlcNAc and lactose per min at 37°C.
Source
Neisseria meningitides
Form
Lyophilized powder
Purity
>95%, determined by SDS-PAGE.
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0